GAPDH and non-small cell lung carcinoma: Previous research showed that high tissue levels of PKM34,35, LDHA36,37, HMOX138, FGFR1OP39, ADAM1010,40, ALDOA41,42, and GAPDH 43,44were correlated with an increased risk of relapse in NSCLC patients.